Estimating Minimally Important Differences for the Bladder Cancer Index Using Distribution and Anchor Based...

Area of Science:

• Urology
• Patient-Reported Outcomes
• Health Outcomes Research

Background:

• The Bladder Cancer Index (BCI) is a validated tool for assessing function and quality of life in bladder cancer patients.
• Interpreting changes in BCI scores requires established thresholds for clinical significance.

Purpose of the Study:

• To establish minimally important difference (MID) score thresholds for the BCI.
• To define clinically meaningful changes in urinary, bowel, and sexual function for bladder cancer survivors.

Main Methods:

• A prospective cohort of 138 patients undergoing radical cystectomy was followed for 1 year.
• Minimally important differences were estimated using distribution-based (1/3 and 1/2 SD) and anchor-based methods, referencing the SF-36.
• BCI and SF-36 questionnaires were administered pre- and post-operatively at 3, 6, and 12 months.

Main Results:

• Distribution-based MIDs for urinary, bowel, and sexual domains ranged from 5.3–10.9, 4.6–8.4, and 6.0–13.5 points, respectively.
• Anchor-based MIDs were estimated at 6.2, 7.3, and 6.8 points for the respective domains.
• Aggregated MIDs across both methods ranged from 5–9 (urinary), 5–8 (bowel), and 7–11 (sexual) points.

Conclusions:

• This study provides the first minimally important difference estimates for the Bladder Cancer Index (BCI).
• These established thresholds are crucial for interpreting patient-reported outcome changes in clinical practice and research for bladder cancer patients.